MONOAMINE REUPTAKE INHIBITORS FOR TREATMENT OF CNS DISORDERS
摘要
The present invention relates to compounds that are a useful exhibit activity as serotonin, norepinephrine and dopamine reuptake inhibitors, and their pharmaceutically acceptable salts, and their use in the treatment of central nervous system and other disorders.